Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
International Journal of Epidemiology
|
September 30, 2009
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study
Marina B Klein, Sahar Saeed, Hong Yang, et al.
Emerging Infectious Diseases
|
January 20, 2012
Intestinal toxemia botulism in 3 adults, Ontario, Canada, 2006-2008
Yolanda D Sheppard, Dean Middleton, Yvonne Whitfield, et al.
Plos One
|
September 27, 2013
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals
Manal Tadros, Victoria Williams, Brenda L Coleman, et al.
Lancet (London, England)
|
February 7, 2021
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
Johan A Maertens, Galia Rahav, Dong-Gun Lee, et al.
BMJ Open
|
December 14, 2021
Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study
Julie C Reid, Andrew P Costa, MyLinh Duong, et al.
The Journal of Antimicrobial Chemotherapy
|
October 14, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Oliver A Cornely, Michael N Robertson, Shariq Haider, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Oliver A Cornely, Michael N Robertson, Shariq Haider, et al.
The New England Journal of Medicine
|
December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Journal of Hepatology
|
June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
Sergio M Borgia, Janet Dearden, Eric M Yoshida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 25, 2015
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons
Laurence Brunet, Erica E M Moodie, Jim Young, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
International Journal of Epidemiology
|
September 30, 2009
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study
Marina B Klein, Sahar Saeed, Hong Yang, et al.
Emerging Infectious Diseases
|
January 20, 2012
Intestinal toxemia botulism in 3 adults, Ontario, Canada, 2006-2008
Yolanda D Sheppard, Dean Middleton, Yvonne Whitfield, et al.
Plos One
|
September 27, 2013
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals
Manal Tadros, Victoria Williams, Brenda L Coleman, et al.
Lancet (London, England)
|
February 7, 2021
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
Johan A Maertens, Galia Rahav, Dong-Gun Lee, et al.
BMJ Open
|
December 14, 2021
Functional recovery following hospitalisation of patients diagnosed with COVID-19: a protocol for a longitudinal cohort study
Julie C Reid, Andrew P Costa, MyLinh Duong, et al.
The Journal of Antimicrobial Chemotherapy
|
October 14, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Oliver A Cornely, Michael N Robertson, Shariq Haider, et al.
The Journal of Antimicrobial Chemotherapy
|
September 30, 2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
Oliver A Cornely, Michael N Robertson, Shariq Haider, et al.
The New England Journal of Medicine
|
December 7, 2017
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
Francisco M Marty, Per Ljungman, Roy F Chemaly, et al.
Journal of Hepatology
|
June 14, 2019
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
Sergio M Borgia, Janet Dearden, Eric M Yoshida, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 25, 2015
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons
Laurence Brunet, Erica E M Moodie, Jim Young, et al.
Page
of 6